Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

56.12
-1.2300-2.14%
Post-market: 56.190.0700+0.12%17:40 EDT
Volume:4.00M
Turnover:224.88M
Market Cap:113.85B
PE:15.02
High:56.51
Open:56.48
Low:55.95
Close:57.35
52wk High:61.70
52wk Low:35.45
Shares:2.03B
Float Shares:1.95B
Volume Ratio:1.19
T/O Rate:0.21%
Dividend:1.78
Dividend Rate:3.17%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:43.31%
ROA:9.79%
PB:5.15
PE(LYR):15.02

Loading ...

GSK Slides Tuesday, Underperforms Market

Dow Jones
·
5 hours ago

GSK Discloses Dividend-Funded ADS Purchase by Chief People Officer

TIPRANKS
·
Apr 20

AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge

MT Newswires Live
·
Apr 20

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

GlobeNewswire
·
Apr 20

GSK says NMPA of China approved Blenrep with bortezomib, dexamethasone

TIPRANKS
·
Apr 20

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Apr 20

GSK Says China Approves Blood Cancer Treatment Combination

MT Newswires Live
·
Apr 20

GSK Expands Treasury Stock With Latest £7m Share Buyback Tranche

TIPRANKS
·
Apr 20

GlaxoSmithKline's Belantamab Mafodotin Receives Marketing Approval in China

Stock News
·
Apr 17

GSK’s New Pneumonia Vaccine Trial Targets a Growing Adult Market

TIPRANKS
·
Apr 17

GSK Adds 325,000 Shares to Treasury in Ongoing Buyback Programme

TIPRANKS
·
Apr 16

GSK Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 16

GSK Completes $950 Million Acquisition of 35Pharma to Boost Pulmonary Hypertension Pipeline

MT Newswires Live
·
Apr 15

Citizens biotechnology analyst holds analyst/industry conference call

TIPRANKS
·
Apr 15

GSK Executives Acquire Shares Under Company Reward Plan

TIPRANKS
·
Apr 14

GSK Executives Reinvest Dividends in Routine Insider Share Purchases

TIPRANKS
·
Apr 13

J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Apr 13

GlaxoSmithKline (GSK) Receives a Buy from Jefferies

TIPRANKS
·
Apr 13

“A Blockbuster? Yes, Absolutely” — GlaxoSmithKline (GSK) Stock Slides despite Morez Hype

TIPRANKS
·
Apr 13

GSK Drug Candidate Shows Potential in Gynecological Cancers -- Market Talk

Dow Jones
·
Apr 13